A Curious Case of Chronic Eosinophilic Pneumonia

Abstract

Chronic eosinophilic pneumonia (CEP) is an idiopathic disorder characterized by an abnormal and marked accumulation of eosinophils in the interstitial and alveolar spaces of the lung. Idiopathic chronic eosinophilic pneumonia is reported to comprise anywhere from 0-2.5% of cases within the registries of interstitial lung disease. Diagnosis is based on the clinical constellation of symptoms, characteristic radiographic findings and peripheral blood or BAL eosinophilia, in the absence of infection or drug-induced eosinophilia. There is no consensus on the dose and duration of treatment, but most authors recommend initial doses of prednisone at 0.5–1 mg/kg/day with gradual tapering of the dose for total treatment duration of 6–12 months.

Two Different Thiosemicarbazone Tauto‐Conformers Coordinate to Palladium (II). Stability and Biological Studies of the Final Complexes

“…When the ring is asymmetrically substituted, it is difficult to separate both forms as the interconversion take place quickly. The synthesis and biological role of thiosemicarbazones bearing imidazole as substituent has been reported [6] but there is very scarce information about their metallic complexes. In the examples reported with TSCN, their substituents seemed to have an important impact in the final compound activity.…”

Πανελλήνια Οροεπιδημιολογική Μελέτη Του Επιπολασμού Της Ηπατίτιδας Α Σε Αντιπροσωπευτικό Δείγμα Παιδιών Ηλικίας 0 - 14 Ετών

“…Ζ αζιόθοζδ επζηαπύκεηεαζ ζε αζεεκείξ ιε έθθεζρδ G6PD (Huo TI et al, 1996;Siddiqui T et al, 1998). Δπζπνόζεεηα, δ επζαίςζδ ηςκ ενοενμηοηηάνςκ ιπμνεί κα ιεζςεεί από μλεία δπαηίηζδα (Katz R et al, 1964).…”